BTIS
AERI

BB&T Investment Services’s Aerie Pharmaceuticals AERI Stock Holding History

BB&T Investment Services’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$1K Hold
13
– – ﹤0.01% 1397
2017
Q3 		$1K Buy
+13
New +$709 ﹤0.01% 1230

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BB&T Investment Services's AERI Position: Q4 2017 in Review

BB&T Investment Services held its Aerie Pharmaceuticals (AERI) position steady in Q4 2017 at 13 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1397.

BB&T Investment Services first reported a position in AERI in Q3 2017 and has held it in 2 quarters since. 179 funds tracked by Wall St. Rank hold AERI as of Q4 2017.

  • BB&T Investment Services held 13 shares of Aerie Pharmaceuticals worth $1K as of Q4 2017.
  • BB&T Investment Services left its Aerie Pharmaceuticals share count unchanged in Q4 2017.
  • Aerie Pharmaceuticals made up ﹤0.01% of BB&T Investment Services's portfolio in Q4 2017, its #1397 holding.
  • BB&T Investment Services first reported a position in Aerie Pharmaceuticals in Q3 2017 and has held it in 2 quarters since.
  • 179 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.